Phase I Study on the Feasibility and Safety of Surgical Stabilizer Assisted Retinal Vein Cannulation With Ocriplasmin Infusion for Central Retinal Vein Occlusion.

Trial Profile

Phase I Study on the Feasibility and Safety of Surgical Stabilizer Assisted Retinal Vein Cannulation With Ocriplasmin Infusion for Central Retinal Vein Occlusion.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Jan 2017

At a glance

  • Drugs Ocriplasmin (Primary)
  • Indications Central retinal vein occlusion
  • Focus Adverse reactions
  • Acronyms RVC_CRVO
  • Most Recent Events

    • 04 Jan 2017 Status changed from not yet recruiting to recruiting.
    • 07 Jul 2016 Planned number of patients changed from 30 to 6.
    • 07 Jul 2016 Planned initiation date changed from 1 Jun 2016 to 1 Aug 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top